COVID-19 Impact on Global Intramuscular Drug Delivery Market Size, Status and Forecast 2020-2026

September 2020 | 99 pages | ID: CA7ACD3CE32FEN
QYResearch

Abstracts

This report focuses on the global Intramuscular Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intramuscular Drug Delivery development in North America, Europe, China and Japan.
The key players covered in this study

• Antares Pharma
• Eli Lily
• Galaxo
• HMD pharmaceuticals
• Inovio Pharmaceuticals
• Merck
• Novartis
• Pacira Pharmaceuticals
• Pfizer
• Pharmajet
• Teva Pharmaceutical

Market segment by Type, the product can be split into

• Drug Molecule
• Delivery Devices

Market segment by Application, split into

• Infectious Disease
• Oncology
• Autoimmune Diseases

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global Intramuscular Drug Delivery status, future forecast, growth opportunity, key market and key players.
• To present the Intramuscular Drug Delivery development in North America, Europe, China and Japan.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Intramuscular Drug Delivery are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intramuscular Drug Delivery Revenue
1.4 Market Analysis by Type
  1.4.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drug Molecule
  1.4.3 Delivery Devices
1.5 Market by Application
  1.5.1 Global Intramuscular Drug Delivery Market Share by Application: 2020 VS 2026
  1.5.2 Infectious Disease
  1.5.3 Oncology
  1.5.4 Autoimmune Diseases
1.6 Coronavirus Disease 2019 (Covid-19): Intramuscular Drug Delivery Industry Impact
  1.6.1 How the Covid-19 is Affecting the Intramuscular Drug Delivery Industry
    1.6.1.1 Intramuscular Drug Delivery Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Intramuscular Drug Delivery Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Intramuscular Drug Delivery Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Intramuscular Drug Delivery Market Perspective (2015-2026)
2.2 Intramuscular Drug Delivery Growth Trends by Regions
  2.2.1 Intramuscular Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Intramuscular Drug Delivery Historic Market Share by Regions (2015-2020)
  2.2.3 Intramuscular Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Intramuscular Drug Delivery Market Growth Strategy
  2.3.6 Primary Interviews with Key Intramuscular Drug Delivery Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Intramuscular Drug Delivery Players by Market Size
  3.1.1 Global Top Intramuscular Drug Delivery Players by Revenue (2015-2020)
  3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2015-2020)
  3.1.3 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Intramuscular Drug Delivery Market Concentration Ratio
  3.2.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2019
3.3 Intramuscular Drug Delivery Key Players Head office and Area Served
3.4 Key Players Intramuscular Drug Delivery Product Solution and Service
3.5 Date of Enter into Intramuscular Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Intramuscular Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Intramuscular Drug Delivery Forecasted Market Size by Type (2021-2026)

5 INTRAMUSCULAR DRUG DELIVERY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Intramuscular Drug Delivery Market Size by Application (2015-2020)
5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Intramuscular Drug Delivery Market Size (2015-2020)
6.2 Intramuscular Drug Delivery Key Players in North America (2019-2020)
6.3 North America Intramuscular Drug Delivery Market Size by Type (2015-2020)
6.4 North America Intramuscular Drug Delivery Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Intramuscular Drug Delivery Market Size (2015-2020)
7.2 Intramuscular Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Intramuscular Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Intramuscular Drug Delivery Market Size by Application (2015-2020)

8 CHINA

8.1 China Intramuscular Drug Delivery Market Size (2015-2020)
8.2 Intramuscular Drug Delivery Key Players in China (2019-2020)
8.3 China Intramuscular Drug Delivery Market Size by Type (2015-2020)
8.4 China Intramuscular Drug Delivery Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Intramuscular Drug Delivery Market Size (2015-2020)
9.2 Intramuscular Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Intramuscular Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Intramuscular Drug Delivery Market Size by Application (2015-2020)

10 KEY PLAYERS PROFILES

10.1 Antares Pharma
  10.1.1 Antares Pharma Company Details
  10.1.2 Antares Pharma Business Overview and Its Total Revenue
  10.1.3 Antares Pharma Intramuscular Drug Delivery Introduction
  10.1.4 Antares Pharma Revenue in Intramuscular Drug Delivery Business (2015-2020))
  10.1.5 Antares Pharma Recent Development
10.2 Eli Lily
  10.2.1 Eli Lily Company Details
  10.2.2 Eli Lily Business Overview and Its Total Revenue
  10.2.3 Eli Lily Intramuscular Drug Delivery Introduction
  10.2.4 Eli Lily Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.2.5 Eli Lily Recent Development
10.3 Galaxo
  10.3.1 Galaxo Company Details
  10.3.2 Galaxo Business Overview and Its Total Revenue
  10.3.3 Galaxo Intramuscular Drug Delivery Introduction
  10.3.4 Galaxo Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.3.5 Galaxo Recent Development
10.4 HMD pharmaceuticals
  10.4.1 HMD pharmaceuticals Company Details
  10.4.2 HMD pharmaceuticals Business Overview and Its Total Revenue
  10.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Introduction
  10.4.4 HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.4.5 HMD pharmaceuticals Recent Development
10.5 Inovio Pharmaceuticals
  10.5.1 Inovio Pharmaceuticals Company Details
  10.5.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
  10.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Introduction
  10.5.4 Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.5.5 Inovio Pharmaceuticals Recent Development
10.6 Merck
  10.6.1 Merck Company Details
  10.6.2 Merck Business Overview and Its Total Revenue
  10.6.3 Merck Intramuscular Drug Delivery Introduction
  10.6.4 Merck Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.6.5 Merck Recent Development
10.7 Novartis
  10.7.1 Novartis Company Details
  10.7.2 Novartis Business Overview and Its Total Revenue
  10.7.3 Novartis Intramuscular Drug Delivery Introduction
  10.7.4 Novartis Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.7.5 Novartis Recent Development
10.8 Pacira Pharmaceuticals
  10.8.1 Pacira Pharmaceuticals Company Details
  10.8.2 Pacira Pharmaceuticals Business Overview and Its Total Revenue
  10.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Introduction
  10.8.4 Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.8.5 Pacira Pharmaceuticals Recent Development
10.9 Pfizer
  10.9.1 Pfizer Company Details
  10.9.2 Pfizer Business Overview and Its Total Revenue
  10.9.3 Pfizer Intramuscular Drug Delivery Introduction
  10.9.4 Pfizer Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.9.5 Pfizer Recent Development
10.10 Pharmajet
  10.10.1 Pharmajet Company Details
  10.10.2 Pharmajet Business Overview and Its Total Revenue
  10.10.3 Pharmajet Intramuscular Drug Delivery Introduction
  10.10.4 Pharmajet Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.10.5 Pharmajet Recent Development
10.11 Teva Pharmaceutical
  10.11.1 Teva Pharmaceutical Company Details
  10.11.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  10.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Introduction
  10.11.4 Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2015-2020)
  10.11.5 Teva Pharmaceutical Recent Development

11 ANALYST'S VIEWPOINTS/CONCLUSIONS

12 APPENDIX

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Intramuscular Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Intramuscular Drug Delivery Revenue
Table 3. Ranking of Global Top Intramuscular Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Intramuscular Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Molecule
Table 6. Key Players of Delivery Devices
Table 7. COVID-19 Impact Global Market: (Four Intramuscular Drug Delivery Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Intramuscular Drug Delivery Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Intramuscular Drug Delivery Players to Combat Covid-19 Impact
Table 12. Global Intramuscular Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Intramuscular Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Intramuscular Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Intramuscular Drug Delivery Market Share by Regions (2015-2020)
Table 16. Global Intramuscular Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Intramuscular Drug Delivery Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Intramuscular Drug Delivery Market Growth Strategy
Table 22. Main Points Interviewed from Key Intramuscular Drug Delivery Players
Table 23. Global Intramuscular Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 24. Global Intramuscular Drug Delivery Market Share by Players (2015-2020)
Table 25. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intramuscular Drug Delivery as of 2019)
Table 26. Global Intramuscular Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Intramuscular Drug Delivery Product Solution and Service
Table 29. Date of Enter into Intramuscular Drug Delivery Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Intramuscular Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 32. Global Intramuscular Drug Delivery Market Size Share by Type (2015-2020)
Table 33. Global Intramuscular Drug Delivery Revenue Market Share by Type (2021-2026)
Table 34. Global Intramuscular Drug Delivery Market Size Share by Application (2015-2020)
Table 35. Global Intramuscular Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 36. Global Intramuscular Drug Delivery Market Size Share by Application (2021-2026)
Table 37. North America Key Players Intramuscular Drug Delivery Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Intramuscular Drug Delivery Market Share (2019-2020)
Table 39. North America Intramuscular Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 40. North America Intramuscular Drug Delivery Market Share by Type (2015-2020)
Table 41. North America Intramuscular Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 42. North America Intramuscular Drug Delivery Market Share by Application (2015-2020)
Table 43. Europe Key Players Intramuscular Drug Delivery Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Intramuscular Drug Delivery Market Share (2019-2020)
Table 45. Europe Intramuscular Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Intramuscular Drug Delivery Market Share by Type (2015-2020)
Table 47. Europe Intramuscular Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Intramuscular Drug Delivery Market Share by Application (2015-2020)
Table 49. China Key Players Intramuscular Drug Delivery Revenue (2019-2020) (Million US$)
Table 50. China Key Players Intramuscular Drug Delivery Market Share (2019-2020)
Table 51. China Intramuscular Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 52. China Intramuscular Drug Delivery Market Share by Type (2015-2020)
Table 53. China Intramuscular Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 54. China Intramuscular Drug Delivery Market Share by Application (2015-2020)
Table 55. Japan Key Players Intramuscular Drug Delivery Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Intramuscular Drug Delivery Market Share (2019-2020)
Table 57. Japan Intramuscular Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Intramuscular Drug Delivery Market Share by Type (2015-2020)
Table 59. Japan Intramuscular Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Intramuscular Drug Delivery Market Share by Application (2015-2020)
Table 61. Antares Pharma Company Details
Table 62. Antares Pharma Business Overview
Table 63. Antares Pharma Product
Table 64. Antares Pharma Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 65. Antares Pharma Recent Development
Table 66. Eli Lily Company Details
Table 67. Eli Lily Business Overview
Table 68. Eli Lily Product
Table 69. Eli Lily Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 70. Eli Lily Recent Development
Table 71. Galaxo Company Details
Table 72. Galaxo Business Overview
Table 73. Galaxo Product
Table 74. Galaxo Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 75. Galaxo Recent Development
Table 76. HMD pharmaceuticals Company Details
Table 77. HMD pharmaceuticals Business Overview
Table 78. HMD pharmaceuticals Product
Table 79. HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 80. HMD pharmaceuticals Recent Development
Table 81. Inovio Pharmaceuticals Company Details
Table 82. Inovio Pharmaceuticals Business Overview
Table 83. Inovio Pharmaceuticals Product
Table 84. Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 85. Inovio Pharmaceuticals Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Product
Table 89. Merck Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 90. Merck Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Pacira Pharmaceuticals Business Overview
Table 97. Pacira Pharmaceuticals Product
Table 98. Pacira Pharmaceuticals Company Details
Table 99. Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 100. Pacira Pharmaceuticals Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Product
Table 104. Pfizer Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 105. Pfizer Recent Development
Table 106. Pharmajet Company Details
Table 107. Pharmajet Business Overview
Table 108. Pharmajet Product
Table 109. Pharmajet Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 110. Pharmajet Recent Development
Table 111. Teva Pharmaceutical Company Details
Table 112. Teva Pharmaceutical Business Overview
Table 113. Teva Pharmaceutical Product
Table 114. Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2015-2020) (Million US$)
Table 115. Teva Pharmaceutical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Intramuscular Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Drug Molecule Features
Figure 3. Delivery Devices Features
Figure 4. Global Intramuscular Drug Delivery Market Share by Application: 2020 VS 2026
Figure 5. Infectious Disease Case Studies
Figure 6. Oncology Case Studies
Figure 7. Autoimmune Diseases Case Studies
Figure 8. Intramuscular Drug Delivery Report Years Considered
Figure 9. Global Intramuscular Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Intramuscular Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 11. Global Intramuscular Drug Delivery Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Intramuscular Drug Delivery Market Share by Players in 2019
Figure 14. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intramuscular Drug Delivery as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Intramuscular Drug Delivery Revenue in 2019
Figure 16. North America Intramuscular Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Intramuscular Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Intramuscular Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Intramuscular Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. Antares Pharma Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 22. Eli Lily Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Eli Lily Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 24. Galaxo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Galaxo Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 26. HMD pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. HMD pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 28. Inovio Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Inovio Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 30. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 32. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Novartis Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 34. Pacira Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pacira Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 36. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Pfizer Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 38. Pharmajet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pharmajet Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 40. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Teva Pharmaceutical Revenue Growth Rate in Intramuscular Drug Delivery Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed